Form 10-Q · Quarterly report
Delta Air Lines 10-Q, filed Oct 9, 2026
- Filed
- CIK
- 0000027904
- Accession no.
- 0000027904-26-000038
Summary
Delta Air Lines reported September 2026 quarter operating income of $1.5 billion, down $230 million from a year earlier, as total revenue rose 21% to $20.2 billion and total operating expense rose 25% to $18.7 billion. Passenger revenue increased 15% on broad-based demand, while aircraft fuel costs rose sharply and non-operating results swung to a $380 million expense.
Key points
- Total operating revenue was $20.186 billion in the September 2026 quarter, up $3.513 billion or 21% year over year, with passenger revenue up 15% to $15.534 billion.
- Operating income was $1.5 billion, a decrease of $230 million from the September 2025 quarter; total operating expense rose 25% to $18.732 billion.
- Aircraft fuel and related taxes increased $1.8 billion on a 63% increase in average jet fuel purchase price.
- Operating activities generated $1.7 billion in cash, free cash flow was $463 million, and liquidity was $6.9 billion as of September 30, 2026; remuneration from American Express was $2.3 billion.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our Condensed Consolidated Financial Statements and the related notes and other financial information included elsewhere in this Quarterly Report on Form 10-Q and our audited Consolidated Financial Statements and related notes included in our 2025 Form 10-K. September 2026 Quarter Financial Highlights Our operating income for the September 2026 quarter was $1.5 billion, a decrease of $230 million compared to the September 2025 quarter. Revenue. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.